ChemicalBook >> CAS DataBase List >>LACTO-N-FUCOPENTAOSE III
LACTO-N-FUCOPENTAOSE III
- CAS No.
- 25541-09-7
- Chemical Name:
- LACTO-N-FUCOPENTAOSE III
- Synonyms
- LNFP III;LEX;ELFT;3-FAL;FUTIV;LNF III;LNF III-GEL;CD15 ANTIGEN;LE(X)-LACTOSE;Lewis X (Lex)
- CBNumber:
- CB0289111
- Molecular Formula:
- C32H55NO25
- Molecular Weight:
- 853.77
- MDL Number:
- MFCD00214316
- MOL File:
- 25541-09-7.mol
- MSDS File:
- SDS
- TDS File:
- TDS
Last updated:2026-04-24 14:58:35
| Product description | Number | Pack Size | Price |
| O-6-Deoxy-α-L-galactopyranosyl-(1→3)-O-[β-D-galactopyranosyl-(1→4)]-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-D-glucose ≥90% | AA007MPH | 1mg | $1226 |
| Lacto-N-fucopentaose III | HY-N11451 | 1mg | $1509 |
| Lacto-N-fucopentaose III | 297298 | 1mg | $1677 |
| Lacto-N-fucopentaose III | OL04212 | 0.5mg | $465 |
| Lacto-N-fucopentaose III | OL04212 | 1mg | $865 |
| Boiling point | 1264.6±65.0 °C(Predicted) |
|---|---|
| Density | 1.71±0.1 g/cm3(Predicted) |
| storage temp. | 2-8°C |
| pka | 12.39±0.20(Predicted) |
| InChIKey | CMQZRJBJDCVIEY-PVRYHJNXNA-N |
| FDA UNII | JRK5FGA8LX |
SAFETY
Risk and Safety Statements
| Hazard Codes | B |
|---|---|
| WGK Germany | 3 |
| HS Code | 29400090 |
LACTO-N-FUCOPENTAOSE III price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| aablocks | AA007MPH | O-6-Deoxy-α-L-galactopyranosyl-(1→3)-O-[β-D-galactopyranosyl-(1→4)]-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-D-glucose ≥90% | 25541-09-7 | 1mg | $1226 | 2026-05-28 | Buy |
| Arctom | HY-N11451 | Lacto-N-fucopentaose III | 25541-09-7 | 1mg | $1509 | 2026-05-26 | Buy |
| Usbiological | 297298 | Lacto-N-fucopentaose III | 25541-09-7 | 1mg | $1677 | 2021-12-16 | Buy |
| Biosynth | OL04212 | Lacto-N-fucopentaose III | 25541-09-7 | 0.5mg | $465 | 2021-12-16 | Buy |
| Biosynth | OL04212 | Lacto-N-fucopentaose III | 25541-09-7 | 1mg | $865 | 2021-12-16 | Buy |
LACTO-N-FUCOPENTAOSE III Chemical Properties,Uses,Production
Chemical Properties
solid
Uses
Lacto-N-fucopentaose III (Cas# 25541-09-7) is a human milk oilgosaccharide. It can inhibit the adherence of pathogens to the intestinal epithelium.
in vivo
Lacto-N-fucopentaose III glycan (50 μg/mouse; i.v.; twice a week for 2 weeks) significantly reduces the severity of experimental autoimmune encephalomyelitis (EAE) and CNS inflammation, and skews peripheral immune response to a Th2 dominant profile in mice[1].
Lacto-N-fucopentaose III (35 μg dextran conjugate/mouse; s.c.; daily for 2 weeks) ameliorates acute and persisting hippocampal synaptic plasticity and transmission deficits in a Gulf War Illness mouse model[2].
LACTO-N-FUCOPENTAOSE III Preparation Products And Raw materials
Raw materials
Preparation Products
LACTO-N-FUCOPENTAOSE III Suppliers
Global( 44)Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| BOC Sciences | +1-631-485-4226 | inquiry@bocsci.com | United States | 19553 | 58 |
| Aladdin Scientific | tp@aladdinsci.com | United States | 52923 | 58 | |
| J & K SCIENTIFIC LTD. | 18210857532; 18210857532 | jkinfo@jkchemical.com | China | 96815 | 76 |
| Hunan Hui Bai Shi Biotechnology Co., Ltd. | 0731-85526065 13308475853 | ivy@hnhbsj.com | China | 7241 | 62 |
| Hangzhou Dingyan Chem Co., LTD | 0571-87157530-8001 13616748242 | sales@dingyanchem.com | China | 2616 | 58 |
| Shanghai YuanYe Biotechnology Co., Ltd. | 021-61312847; 18021002903 | 3008007409@qq.com | China | 89686 | 60 |
| Chengdu Push Bio-Technology Co., Ltd. | 028-85370565-229 18080489829 | 18080489829@163.com | China | 7982 | 60 |
| Shenzhen Polymeri Biochemical Technology Co., Ltd. | +86-400-002-6226 +86-13028896684; | sales@rrkchem.com | China | 57422 | 58 |
| BOC Sciences | 16314854226 | inquiry@bocsci.com | United States | 9713 | 58 |
| Wuhan Tangzhi Pharmaceutical Co., Ltd. | 027-63498076 13658392159 | sale@glycogene.com | China | 838 | 58 |
25541-09-7(LACTO-N-FUCOPENTAOSE III)Related Search:
LACTO-N-FUCOPENTAOSE V
N-[(2S,3R,4R,5S,6R)-5-hydroxy-6-(hydroxymethyl)-2-[(2S,3R,4S,5S,6R)-2,3,5-trihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]acetamide
LACTO-N-NEOTETRAOSE
Fucoxanthin
LACTO-N-FUCOPENTAOSE I
1of4
GAL-BETA1,4(FUC-ALPHA1,3)GLCNAC-BETA1,3GAL-BETA1,4GLC
LEWIS-X PENTASACCHARIDE
LEWIS-X-PENTASACCHARIDE-GEL
LEX
LE(X)-LACTOSE
LEX-PENTASACCHARIDE
LACTO-N-FUCOPENTAOSE III
LACTO-N-FUCOPENTAOSE III-GEL
LACTO-N-FUCOPENTAOSE III, HUMAN MILK
III3FUC-NLCOSE4
BETA-D-GAL-[1->4]-(ALPHA-L-FUC-[1->3])-BETA-D-GLCNAC-[1->3]-BETA-D-GAL-[1->4]-D-GLC
LNF III
LNF III-GEL
Lacto-N-fucopentaose Ⅲ
lacto-N-fucopentaose iii*from human milk
β-d-gal-(1→4)-[α-l-fuc-(1→3)]-β-d-glcnac-(1→3)-β-d-gal-(1→4)-d-glc
N-[2-[3,5-dihydroxy-2-(hydroxymethyl)-6-(1,2,4,5-tetrahydroxy-6-oxohexan-3-yl)oxyoxan-4-yl]oxy-6-(hydroxymethyl)-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-3-yl]acetamide
Lex-lactose, Lewis-X pentasaccharide, LNFP III, β-D-Gal-(1-4)-[α-L-Fuc-(1-3)]-β-D-GlcNAc-(1-3)-β-D-Gal-(1-4)-D-Glc
Lacto-N-fucopentaose III ,95%
D-Glucose, O-6-deoxy-α-L-galactopyranosyl-(1→3)-O-[β-D-galactopyranosyl-(1→4)]-O-2-(acetylamino)-2-deoxy-β-D-glucopyranosyl-(1→3)-O-β-D-galactopyranosyl-(1→4)-
Lewis X antigen
Galβ1,4(Fucα1,3)GlcNAcβ1,3Galβ1,4Glc
Gal-b-1,4-(Fuc-a-1,3)-GlcNAc-b-1,3-D-Gal-b-1,4-Glc
CD15 ANTIGEN
3-FAL
ELFT
FUTIV
Lewis X (Lex)
LNFP III
25541-09-7
C32H55NO25H2O
BioChemical
Carbohydrate Analysis
Carbohydrate Standards
Proteomics
Proteomics and Protein Expression
Post-translational Modification
